International Biotechnology Trust as of Dec. 31, 2020
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 52 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics Pub SHS | 8.9 | $33M | 444k | 73.16 | |
| ACADIA Pharmaceuticals (ACAD) | 7.1 | $26M | 486k | 53.46 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.3 | $23M | 97k | 236.11 | |
| BioMarin Pharmaceutical (BMRN) | 5.9 | $22M | 248k | 87.57 | |
| Ptc Therapeutics I (PTCT) | 5.6 | $20M | 333k | 61.03 | |
| Gilead Sciences (GILD) | 5.5 | $20M | 348k | 58.24 | |
| Biohaven Pharmaceutical Holding | 4.7 | $17M | 200k | 85.72 | |
| Amgen (AMGN) | 4.5 | $17M | 72k | 229.83 | |
| Chemocentryx | 4.3 | $16M | 256k | 61.75 | |
| Alexion Pharmaceuticals | 4.2 | $16M | 99k | 156.12 | |
| Mirati Therapeutics | 4.0 | $15M | 67k | 219.64 | |
| Turning Point Therapeutics I | 3.8 | $14M | 114k | 121.68 | |
| Halozyme Therapeutics (HALO) | 3.6 | $13M | 308k | 42.70 | |
| Seagen | 3.1 | $12M | 66k | 175.13 | |
| Exelixis (EXEL) | 2.9 | $11M | 527k | 20.07 | |
| Acceleron Pharma | 2.5 | $9.1M | 71k | 127.65 | |
| Biogen Idec (BIIB) | 2.2 | $8.0M | 33k | 244.51 | |
| Incyte Corporation (INCY) | 1.9 | $6.8M | 78k | 86.87 | |
| Regeneron Pharmaceuticals (REGN) | 1.5 | $5.5M | 12k | 482.52 | |
| Sarepta Therapeutics (SRPT) | 1.5 | $5.4M | 32k | 170.29 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $4.7M | 36k | 129.97 | |
| Ionis Pharmaceuticals (IONS) | 1.2 | $4.4M | 78k | 56.54 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $3.4M | 177k | 18.99 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.9 | $3.4M | 22k | 153.09 | |
| Protagonist Therapeutics (PTGX) | 0.8 | $3.1M | 152k | 20.16 | |
| Sutro Biopharma (STRO) | 0.8 | $3.0M | 139k | 21.63 | |
| Deciphera Pharmaceuticals | 0.8 | $2.9M | 50k | 57.06 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $2.7M | 58k | 46.43 | |
| Intra Cellular Therapies (ITCI) | 0.7 | $2.5M | 80k | 31.80 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $2.3M | 24k | 95.79 | |
| Ascendis Pharma AS Sponsored ADR (ASND) | 0.6 | $2.3M | 14k | 166.52 | |
| Allakos (ALLK) | 0.6 | $2.2M | 16k | 139.81 | |
| Blueprint Medicines (BPMC) | 0.6 | $2.2M | 20k | 112.15 | |
| Amicus Therapeutics (FOLD) | 0.6 | $2.2M | 95k | 23.10 | |
| Mersana Therapeutics (MRSN) | 0.5 | $1.9M | 72k | 26.54 | |
| Oric Pharmaceuticals (ORIC) | 0.5 | $1.8M | 53k | 33.75 | |
| Arena Pharmaceuticals | 0.4 | $1.6M | 21k | 76.86 | |
| EXACT Sciences Corporation (EXAS) | 0.4 | $1.4M | 11k | 132.52 | |
| GW Pharmaceuticals Ads | 0.3 | $1.2M | 10k | 115.29 | |
| Axsome Therapeutics (AXSM) | 0.3 | $1.1M | 14k | 81.43 | |
| Nektar Therapeutics (NKTR) | 0.3 | $1.1M | 67k | 17.00 | |
| Insmed (INSM) | 0.3 | $1.1M | 34k | 33.30 | |
| Aurinia Pharmaceuticals (AUPH) | 0.3 | $1.1M | 79k | 13.82 | |
| Uniqure Nv SHS (QURE) | 0.3 | $994k | 28k | 36.15 | |
| Global Blood Therapeutics In | 0.3 | $944k | 22k | 43.30 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $932k | 22k | 43.35 | |
| Fibrogen (FGEN) | 0.2 | $731k | 20k | 37.11 | |
| Travere Therapeutics (TVTX) | 0.1 | $545k | 20k | 27.25 | |
| Bluebird Bio (BLUE) | 0.1 | $476k | 11k | 43.27 | |
| Esperion Therapeutics (ESPR) | 0.1 | $247k | 9.5k | 26.00 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $215k | 10k | 21.50 | |
| Zealand Pharma A S Sponsored Adr | 0.1 | $203k | 5.7k | 35.91 |
